Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Plasmacytoma 2Paraproteinemias 2Multiple Myeloma 2Leukemia, Plasma Cell 2Patient Preference 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leiomyoma 1Inflammatory Breast Neoplasms 1Breast Neoplasms 1Agnosia 1Advanced Solid Tumors 1Advanced Cancer 1Abdominal Cancer 1

Interventions

Ropivacaine 6Anesthesia, General 6Analgesics, Opioid 6Morphine 5Acetaminophen 5Saline Solution 4Lidocaine 4Ketamine 4Fentanyl 4Sodium Chloride 3Dexmedetomidine 3Bupivacaine 3Anesthetics, Local 3Anesthesia, Local 3Acupuncture Therapy 3trimebutine 3-thiocarbamoylbenzenesulfonate 2parecoxib 2Transcutaneous Electric Nerve Stimulation 2Tramadol 2Therapeutics 2Tea 2Surveys and Questionnaires 2Propofol 2Oxycodone 2Magnesium Sulfate 2Levobupivacaine 2Control Groups 2ramosetron 1acetaminophen, codeine drug combination 1Varenicline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Agnosia × Injections, Subcutaneous × Clear all
NCT02270255 2019-08-14

Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Completed
44 enrolled 8 charts

Agnosia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡